Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2013
03/13/2013CN102964196A Preparation method of nitrile compound
03/13/2013CN102321084B Method for synthesizing benzo[c]pyridine[4,3,2-mn]acridine-8-one
03/13/2013CN101715450B Azaindole derivatives as CFTR modulators
03/13/2013CN101600717B 2- piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives
03/13/2013CN101094848B Organic compounds
03/12/2013US8394843 Substituted isoindoles as glucokinase activators
03/12/2013US8394831 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
03/12/2013US8394823 Triazolopyridine compounds useful as DGAT1 inhibitors
03/12/2013US8394820 N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
03/12/2013US8394818 Soluble mTOR complexes and modulators thereof
03/12/2013US8394815 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
03/12/2013US8394811 Hydrazide compounds as thyroid hormone receptor modulators and uses thereof
03/12/2013US8394795 Pyrazole [3, 4-B] pyridine Raf inhibitors
03/12/2013US8394789 (Dihydro)pyrrolo[2,1-α]isoquinolines
03/12/2013CA2699568C Azaindoles
03/12/2013CA2668210C Anilinopiperazine derivatives and methods of use thereof
03/07/2013WO2013033620A1 Compounds and compositions as pdgfr kinase inhibitors
03/07/2013WO2013033569A1 Heterocyclylamines as pi3k inhibitors
03/07/2013WO2013033345A1 Immunomodulators and immunomodulator conjugates
03/07/2013WO2013033269A1 Bioorthogonal monomers capable of dimerizing and targeting bromodomains and methods of using same
03/07/2013WO2013033203A1 Compounds and compositions as c-kit kinase inhibitors
03/07/2013WO2013033167A1 Compounds and compositions as c-kit kinase inhibitors
03/07/2013WO2013033116A1 Compounds and compositions as c-kit kinase inhibitors
03/07/2013WO2013033070A1 COMPOUNDS AND COMPOSITIONS AS c-KIT KINASE INHIBITORS
03/07/2013WO2013032939A1 Bicyclic agonists of gpr131 and uses thereof
03/07/2013WO2013030802A1 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
03/07/2013WO2013030735A1 1,6- diazabicyclo [3,2,1] octan- 7 - one derivatives and their use in the treatment of bacterial infections
03/07/2013WO2013030733A1 1,6- diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
03/07/2013WO2013030325A1 Diketopyrrolopyrrole oligomers and compositions, comprising diketopyrrolopyrrole oligomers
03/07/2013WO2013030288A1 Substituted annellated pyrimidine and the use thereof
03/07/2013WO2013029548A1 Quinolone compound
03/07/2013WO2013003315A3 Methods for preparing isoquinolines
03/07/2013WO2013001505A3 Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases
03/07/2013US20130060038 Preparation of dihydropyrrol derivatives as intermediates
03/07/2013US20130059881 Compositions and methods for treating viral diseases
03/07/2013US20130059880 Moxifloxacin hydrochloride compounds and intermediates and methods for making same
03/07/2013US20130059879 Small Molecule Inhibitors of PFKFB3 and Glycolytic Flux and Their Methods of Use as Anti-Cancer Therapeutics
03/07/2013US20130059865 Compounds having antiviral properties
03/07/2013US20130059863 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof
03/07/2013US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions
03/07/2013US20130059850 Aza-indole derivatives useful as modulators of faah
03/07/2013US20130059849 Azaindazoles
03/07/2013US20130059846 Compounds and compositions as c-kit kinase inhibitors
03/07/2013US20130059845 Bicyclic agonists of gpr131 and uses thereof
03/07/2013US20130059837 Benzazepine compound
03/07/2013US20130059835 Heterocyclylamines as pi3k inhibitors
03/07/2013US20130059834 Pyrrolopyrazine kinase inhibitors
03/07/2013US20130059833 Pde10 modulators
03/07/2013US20130059832 Compounds and compositions as c-kit kinase inhibitors
03/07/2013CA2847075A1 Substituted annellated pyrimidine and the use thereof
03/07/2013CA2846652A1 Heterocyclylamines as pi3k inhibitors
03/07/2013CA2845798A1 Compounds and compositions as pdgfr kinase inhibitors
03/07/2013CA2845791A1 Compounds and compositions as c-kit kinase inhibitors
03/07/2013CA2845785A1 Compounds and compositions as c-kit kinase inhibitors
03/07/2013CA2845753A1 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
03/07/2013CA2845459A1 Quinolone compound
03/07/2013CA2845169A1 Compounds and compositions as c-kit kinase inhibitors
03/07/2013CA2845159A1 Compounds and compositions as c-kit kinase inhibitors
03/07/2013CA2845108A1 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections
03/07/2013CA2833241A1 1,6-diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
03/06/2013EP2565195A1 Peripheral opioid receptor and antagonists and uses thereof
03/06/2013EP2565194A1 IMIDAZO[1,2-a]PYRIDINE DERIVATIVE
03/06/2013EP2565185A1 [5,6]heterocyclic compound
03/06/2013EP2563791A1 A process of a quaternary ammonium salt using phosphate
03/06/2013EP2563790A1 A process of a quaternary ammonium salt
03/06/2013EP2563789A1 7-(1h-pyrazol-4-yl)-1,6-naphthyridine compounds as syk inhibitors
03/06/2013EP2563788A1 Naphthridine derivatives as pi3k inhibitors for the treatment of cancer and immune - inflammatory diseases
03/06/2013EP2563787A1 Azaindazole amide compounds as ccr1 receptor antagonists
03/06/2013EP2563126A1 Heterocyclic quinolizine derived m1 receptor positive allosteric modulators
03/06/2013EP2563125A1 Azaindoles as janus kinase inhibitors
03/06/2013CN102958932A Modulators of 5-HT receptors and methods of use thereof
03/06/2013CN102958930A 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer
03/06/2013CN102958929A Phenanthroline compound, electron transport material obtained from said compound, and organic thin-film photovoltaic cell comprising said compound
03/06/2013CN102958925A Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer
03/06/2013CN102958919A Novel tetrahydroquinoline derivatives
03/06/2013CN102958918A Novel nicotinamide derivatives or salts thereof
03/06/2013CN102958906A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/06/2013CN102952151A 3-position bis-beta-carboline alkali compound, and preparation method, pharmaceutical composition and application thereof
03/06/2013CN102952139A Trans-3a-fluoropyrrolidine[3,4-C]benzo cyclocompound and preparation method thereof
03/06/2013CN102952134A Difluoromethyl-containing cytisine derivative, preparation method and antitumous effect research
03/06/2013CN102952133A Method for preparing nevirapine
03/06/2013CN102952132A Novel synthetic method of beta-tetrahydrocarboline compound by using pentamethyleneamine as raw material
03/06/2013CN102952131A Preparation method of moxifloxacin hydrochloride
03/06/2013CN102952130A Method for chiral synthesis of (S,S)-2-8-diazabicyclononane
03/06/2013CN102952129A Tetrahydropyridodihydropyrimidinone derivative, its preparation method and application
03/06/2013CN102076686B Diketopiperidine derivatives as HIV attachment inhibitors
03/06/2013CN102027611B N-type semiconductor materials in thin film transistors
03/05/2013US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression
03/05/2013US8389724 Crystalline salt forms of a 5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazine derivative
03/05/2013US8389720 Quinolone neuropeptide S receptor antagonists
03/05/2013US8389532 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine
03/05/2013US8389518 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
03/05/2013CA2708324C Viral polymerase inhibitors
03/05/2013CA2666258C Antidepressant, neuroprotectant, amyloid .beta. deposition inhibitor or age retardant containing heterocyclic compound having specific structure
02/2013
02/28/2013WO2013026516A1 Bicyclic heteroaromatic compounds
02/28/2013US20130053570 CGRP Receptor Antagonists
02/28/2013US20130053568 2,5-di(methoxyanilino) terephthalic acid polymorphs and quinacridones realized therefrom2,5-di(methoxyanilino) terephthalic acid polymorphs and quinacridones realized therefrom
02/28/2013US20130053555 Organic electroluminescent devices
02/28/2013US20130053412 Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use
02/28/2013US20130053410 Substituted heteroaryl 2',3',7',7a'-tetrahydrospiro[pyrrole-3,6'-pyrrolo[1,2-c]imidazole]-1',2(1h,5'h)-dione
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 646